{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:24:59Z","timestamp":1793809499772,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.arteri.2026.500941","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:48:04Z","timestamp":1779709684000},"page":"500941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Niveles de lipoprote\u00edna(a) y su relaci\u00f3n con la gravedad y discapacidad del ictus isqu\u00e9mico"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6931-1697","authenticated-orcid":false,"given":"\u00c0ngels","family":"Pedragosa Vall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Alija Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faunier","family":"Rios Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Guerrero Buitrago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mauri Pont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Borrallo Almansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamen","family":"Carmona Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2026.500941_bib0190","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2026.500941_bib0195","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","article-title":"Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans","volume":"134","author":"Van der Valk","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2026.500941_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/clc.4960270503","article-title":"Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis","volume":"27","author":"Deb","year":"2004","journal-title":"Clin Cardiol."},{"key":"10.1016\/j.arteri.2026.500941_bib0205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-023-00937-4","article-title":"Oxidized phospholipids in cardiovascular disease","volume":"21","author":"Tsimikas","year":"2024","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.arteri.2026.500941_bib0210","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2026.500941_bib0215","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2026.500941_bib0220","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2026.500941_bib0225","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet."},{"key":"10.1016\/j.arteri.2026.500941_bib0230","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamacardio.2018.1470","article-title":"Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies: a Mendelian randomization analysis","volume":"3","author":"Burgess","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.arteri.2026.500941_bib0235","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"290","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2026.500941_bib0240","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2026.500941_bib0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.atherosclerosis.2023.04.012","article-title":"Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society","volume":"374","author":"Kronenberg","year":"2023","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2026.500941_bib0250","first-page":"133","article-title":"SEA 2024 standards for global control of vascular risk","volume":"36","author":"Mostaza","year":"2024","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2026.500941_bib0255","first-page":"243","article-title":"Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice","volume":"36","author":"Delgado-Lista","year":"2024","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2026.500941_bib0260","doi-asserted-by":"crossref","DOI":"10.23938\/ASSN.0979","article-title":"Prevalence and incidence of ictus in Europe: systematic review and meta-analysis","volume":"45","author":"Soto","year":"2022","journal-title":"An Sist Sanit Navar."},{"key":"10.1016\/j.arteri.2026.500941_bib0265","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2019.03.524","article-title":"Elevated lipoprotein(a) and risk of ischemic stroke","volume":"74","author":"Langsted","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2026.500941_bib0270","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2015.08.021","article-title":"Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis","volume":"242","author":"Nave","year":"2015","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2026.500941_bib0275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/STROKEAHA.116.014436","article-title":"Lipoprotein(a) levels and recurrent vascular events after first ischemic stroke","volume":"48","author":"Lange","year":"2017","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2026.500941_bib0280","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/STROKEAHA.121.034924","article-title":"Effect of lipoprotein(a) on stroke recurrence attenuates at low LDL-C (Low-Density Lipoprotein) and inflammation levels","volume":"53","author":"Xu","year":"2022","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2026.500941_bib0285","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2026.500941_bib0290","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/eurheartj\/ehab251","article-title":"Elevated lipoprotein(a) and the risk of stroke in children, young adults, and the elderly","volume":"42","author":"Tsimikas","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2026.500941_bib0295","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95141-0","article-title":"Lipoprotein(a) level as a risk factor for stroke and its subtype: a systematic review and meta-analysis","volume":"11","author":"Kumar","year":"2021","journal-title":"Sci Rep."},{"key":"10.1016\/j.arteri.2026.500941_bib0300","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/eurheartj\/ehab081","article-title":"Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study","volume":"42","author":"Arnold","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2026.500941_bib0305","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5603\/pjnns.98343","article-title":"Lipoprotein(a) concentration as a risk factor for ischaemic stroke and its subtypes","volume":"58","author":"Lackova","year":"2024","journal-title":"Neurol Neurochir Pol."},{"key":"10.1016\/j.arteri.2026.500941_bib0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119231","article-title":"Residual lipoprotein(a)-associated risk in patients with stroke or transient ischemic attack","volume":"405","author":"Hoshino","year":"2025","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2026.500941_bib0315","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s12640-017-9850-6","article-title":"Elevated lipoprotein (a) and risk of poor functional outcome in Chinese patients with ischemic stroke and type 2 diabetes","volume":"33","author":"Wang","year":"2018","journal-title":"Neurotox Res."},{"key":"10.1016\/j.arteri.2026.500941_bib0320","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12974-021-02359-w","article-title":"Elevated lipoprotein(a) and lipoprotein-associated phospholipase A2 are associated with unfavorable functional outcomes in patients with ischemic stroke","volume":"18","author":"Jiang","year":"2021","journal-title":"J Neuroinflammation."},{"key":"10.1016\/j.arteri.2026.500941_bib0325","volume":"31","author":"Liu","year":"2024","journal-title":"Eur J Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.arteri.2026.500941_bib0330","first-page":"3","volume":"13","author":"Arboix","year":"1998","journal-title":"Neurologia"},{"key":"10.1016\/j.arteri.2026.500941_bib0335","first-page":"192","article-title":"La escala de ictus del National Institute of Health (NIHSS) y su adaptaci\u00f3n al espa\u00f1ol [NIH stroke scale and its adaptation to Spanish]","volume":"21","author":"Montaner","year":"2006","journal-title":"Neurologia."},{"key":"10.1016\/j.arteri.2026.500941_bib0340","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/STROKEAHA.109.571562","article-title":"Improving modified Rankin Scale assessment with a simplified questionnaire","volume":"41","author":"Bruno","year":"2010","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2026.500941_bib0345","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2026.500941_bib0350","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5853\/jos.2024.04623","article-title":"The association of lipoprotein(a) and stroke recurrence: a systematic review and meta-analysis","volume":"27","author":"Palaiodimou","year":"2025","journal-title":"J Stroke."},{"key":"10.1016\/j.arteri.2026.500941_bib0355","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16501","article-title":"Impact of elevated lipoprotein(a) levels on the functional outcomes of ischemic stroke patients: a systematic review and meta-analysis","volume":"31","author":"Liu","year":"2024","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.arteri.2026.500941_bib0360","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/postmj\/qgad070","article-title":"Lipoprotein(a) and functional outcome of acute ischemic stroke when discordant with low-density lipoprotein cholesterol","volume":"99","author":"Dong","year":"2023","journal-title":"Postgrad Med J."},{"key":"10.1016\/j.arteri.2026.500941_bib0365","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.25120","article-title":"Association of lipoprotein-associated phospholipase A2 and lipoprotein(a) with the risk of recurrence stroke in patients with acute ischemic stroke","volume":"38","author":"Feng","year":"2024","journal-title":"J Clin Lab Anal."},{"key":"10.1016\/j.arteri.2026.500941_bib0370","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12974-021-02359-w","article-title":"Elevated lipoprotein(a) and lipoprotein-associated phospholipase A2 are associated with unfavorable functional outcomes in patients with ischemic stroke","volume":"18","author":"Jiang","year":"2021","journal-title":"J Neuroinflammation."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916826000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916826000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:26:43Z","timestamp":1793806003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916826000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0214916826000501"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2026.500941","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niveles de lipoprote\u00edna(a) y su relaci\u00f3n con la gravedad y discapacidad del ictus isqu\u00e9mico","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2026.500941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500941"}}